Neocure tracks and predicts changes in global reimbursement systems, identifying opportunities and barriers for biomedical advancements. Nuances of reimbursement policy—complex and confusing to even experienced health leaders—can severely deter, or expand, adoption of promising innovations.

Neocure translates policy, providing insight on whether it's realistic to maneuver through the government and private payer environment.

Companies should ask:

• What reimbursement opportunities and barriers are most important to companies and investors?
• What are the most important policy decisions that will make a difference to the bottom-line?
• How are reimbursement risks weighed in comparison to regulatory, manufacturing, and product development and market development issues?
• What is the cost of achieving reimbursement success?
• How long will it take policies be realistically changed for business success?
• What policies can we change that will make a difference for your business?

The trusted opinions of key policy makers are incorporated into the advice we give. We know how key general health policy and reimbursement issues will affect your financial needs. For associations, we develop strategic policy platforms based on business realities to serve your members more effectively.

Our advice is built on a combination of skills in market economics from a clinical and business perspective, to provide you with a "reality checkpoint" for investment decisions, or to give you confidence that a credible, realistic reimbursement strategy can be implemented.